More on TGTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+94.1% Growth)
- Ratings (8.6 Score)
- Holders

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

TG Therapeutics (NQ:TGTX)
Delayed: 53.22 +1.72 (3.34%)
Prev. Close $51.50  
Open$52.32 
52 Wk High$14.87 
52 Wk Low$4.90 
Day High$54.07 
Day Low$51.95 
P/E N/A  
EPS$-0.67 
Volume7,172,563 

Friends, Peers and Foes (?): ABBV, ADMA, ALNY, AMGN, ASND (more...)

Jun 15, 2026 05:03 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Lonial Sagar
Jun 15, 2026 05:03 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: HUME DANIEL
Jun 15, 2026 05:02 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Hoberman Kenneth
Jun 15, 2026 05:01 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Echelard Yann
Jun 15, 2026 05:01 PM Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Charney Laurence N
Jun 12, 2026 04:33 PM Form 8-K TG THERAPEUTICS, INC. For: Jun 11
Jun 9, 2026 07:30 AM TG Therapeutics reports positive phase 1 data for BRIUMVI in myasthenia gravis
Jun 9, 2026 07:30 AM TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
Jun 3, 2026 07:34 AM Form 8-K TG THERAPEUTICS, INC. For: Jun 03
Jun 3, 2026 07:30 AM TG Therapeutics reports positive Phase 1 subcutaneous BRIUMVI trial results
View All Articles

Entities mentioned with TGTX

View All Entities